首页> 外文会议>European Meeting on Supercritical Fluids >POROUS CHITOSAN-DRUG FORMULATIONS BY SCeO_2-ASSISTED ATOMIZATION
【24h】

POROUS CHITOSAN-DRUG FORMULATIONS BY SCeO_2-ASSISTED ATOMIZATION

机译:由Sceo_2辅助雾化的多孔壳聚糖 - 药物制剂

获取原文

摘要

This work aims to produce porous biopolymer particles for pharmaceutical applications. In particular chitosan and chitosan ibuprofen-loaded particles are being produced through supercritical CO_2-assisted atomization in a SAA laboratory scale apparatus at NOVA and in a pilot scale PGSS drying apparatus at BOCHUM. Particles were obtained in the range of 2 μm to around 1 mm. Chitosan particles were further impregnated in a batch reactor in scCO_2 and the drug uptake and release profiles compared with the chitosan-ibuprofen co-atomization formulation. The drug release profiles were evaluated by in vitro experiments at PBS pH 7.4 and 37°C. Preliminary results show that the way of loading the particles influence both the impregnation degree of the drug and the release profiles of the formulations.
机译:这项工作旨在产生用于药物应用的多孔生物聚合物颗粒。特别是壳聚糖和壳聚糖布洛芬加载的颗粒是通过在Nova的Saa实验室规模装置中的超临界CO_2辅助雾化制造,并在波鸿的先导尺度PGSS干燥装置中产生。获得的颗粒在2μm至约1mm的范围内。与壳聚糖 - 布洛芬共雾化制剂相比,壳聚糖颗粒在SCCO_2中的分批反应器中进一步浸渍在SCCO_2中的批量反应器中,以及药物吸收和释放曲线。通过PBS pH 7.4和37℃的体外实验评估药物释放型材。初步结果表明,装载颗粒的装载方式影响药物的浸渍程度和制剂的释放轮廓。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号